STAR Market

Vaccine maker AIM Vaccine said on Monday it expects to report a net loss of 1.25 billion yuan to 1.38 billion yuan for last year, roughly quadruple its loss from 2022.

FAST NEWS: AIM Vaccine’s loss balloons

The latest: Vaccine maker AIM Vaccine Co. Ltd. (6660.HK) said on Monday it expects to report a net loss of 1.25 billion yuan ($174 million) to 1.38 billion yuan for last…
6660.HK
AIM Vaccine announced Friday that its shares were selected for inclusion in the MSCI Global Small Cap Index, effective after markets closed on Nov. 30.

FAST NEWS: AIM Vaccine named to MSCI small cap index

The latest: AIM Vaccine Co. Ltd. (6660.HK), China’s second-largest maker of non-Covid vaccines, announced Friday that its shares were selected for inclusion in the MSCI Global Small Cap Index, effective after…
6660.HK

Recent Articles

RELATED ARTICLES

  1. Buoyed by bumper earnings, the biotech has announced a share placement to raise HK$1.17 billion to invest in developing its portfolio of anti-cancer drugs.
    Akeso marks profit milestone with swift rights issue
    9926.HK
  2. Test results for new cancer drug take Akeso investors on wild ride
    9926.HK
  3. BeiGene still bleeding red ink despite blockbuster drug
    BGNE.US 6160.HK 688235.SHG
  4. CSPC Pharma taps R&D superstar in quest for new breakout drugs
    1093.HK
  5. CSPC Pharma weighs up diet drug for bigger bottom line
    1093.HK
  6. Novel drugs lift Sino Biopharm earnings, easing price-cap pain
    1177.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva